Author: Jayatilaka MLT, Philpott MDG, Fisher A, Fisher L, Molloy A, Mason L.
Source: Foot Ankle Int. 2019 Aug 8:1071100719865896.
doi: 10.1177/1071100719865896. [Epub ahead of print]
PMID: 31390895 [PubMed – as supplied by publisher]
Author: Geraldine O'Hagan
Aintree – Socio-Economic Differences in Patient Participation Behaviours in Doctor-Patient Interactions-A Systematic Mapping Review of the Literature
Authors: Allen S, Rogers SN, Harris RV.
Source: Health Expect. 2019 Aug 9.
doi: 10.1111/hex.12956. [Epub ahead of print]
PMID: 31398772 [PubMed – as supplied by publisher]
Aintree – Left Atrial Ejection Fraction and Outcomes in Heart Failure with Preserved Ejection Fraction
Authors: Kanagala P, Arnold JR, Cheng ASH, Singh A, Khan JN, Gulsin GS, Yang J, Zhao L, Gupta P, Squire IB, Ng LL, McCann GP.
Source: Int J Cardiovasc Imaging. 2019 Aug 10.
doi: 10.1007/s10554-019-01684-9. [Epub ahead of print]
PMID: 31401742 [PubMed – as supplied by publisher]
Walton – Health Utilities and Costs for Motor Neurone Disease
Author(s): Moore A.; Hughes D.A.; Young C.A.
Source: Value in Health; 2019
Publication Date: 2019
Publication Type(s): Article
Abstract:Background: Motor neurone disease (MND) places a significant burden on patients, their carers, and healthcare systems. Objective(s): To estimate health utilities and costs of MND within the UK setting. Method(s): Patients with MND, recruited via 22 regional clinics, completed a postal questionnaire of a cost and quality-of-life survey. Health outcome assessment included the EuroQoL (EQ)-5D-5L, EQ-5D-visual analogue scale, Amyotrophic Lateral Sclerosis Utility Index, and the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised. Clinical staging was based on the Kings and Milano-Torino (MiToS) systems. The questionnaire asked about patients’ use of primary, secondary, and community care services in the previous 3 months. Variability in total costs was examined using regression models. Result(s): 595 patients were included in the health utility analysis, of whom 584 patients also completed a resource use questionnaire. Mean health utility decreased and costs increased between consecutive Kings stages, from 0.76 (95% CI 0.71-0.80) and 1096 (757-1240) in Kings stage 1, to 0.50 (0.45-0.54) and 3311 (2666-4151) in stage 4, respectively. The changes by MiToS stages were from 0.71 (0.69-0.73) and 1115 (937-1130) in MiToS stage 0, to 0.25 (0.07-0.42) and 2899 (2190-3840) in stage 2. Kings stages 3 and 4 and MiToS stages 1 and 2, respectively, were significant in explaining variability in total costs. Conclusion(s): The impact of MND on health utilities and costs differs by disease severity. The data provided here can be used in cost-effectiveness analyses and to inform decision-making regarding healthcare provision for people with MND.
Copyright © 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research
Database: EMBASE
Aintree – The Long Limb Bones of the StW 573 Australopithecus Skeleton from Sterkfontein Member 2: Descriptions and Proportions
Authors: Heaton JL, Pickering TR, Carlson KJ, Crompton RH, Jashashvili T, Beaudet A, Bruxelles L, Kuman K, Heile AJ, Stratford D, Clarke RJ.
Source: J Hum Evol. 2019 Aug;133:167-197.
doi: 10.1016/j.jhevol.2019.05.015. Epub 2019 Jul 4.
PMID: 31358179 [PubMed – in process]
Aintree – A Multiscale Stratigraphic Investigation of the Context of StW 573 ‘Little Foot’ and Member 2, Sterkfontein Caves, South Africa
Authors: Bruxelles L, Stratford DJ, Maire R, Pickering TR, Heaton JL, Beaudet A, Kuman K, Crompton R, Carlson KJ, Jashashvili T, McClymont J, Leader GM, Clarke RJ.
Source: J Hum Evol. 2019 Aug;133:78-98.
doi: 10.1016/j.jhevol.2019.05.008. Epub 2019 Jun 26.
PMID: 31358185 [PubMed – in process]
Aintree – Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn’s Disease
Authors: Catt H, Bodger K, Kirkham JJ, Hughes DA.
Source: Pharmacoeconomics. 2019 Aug 2.
doi: 10.1007/s40273-019-00826-0. [Epub ahead of print]
PMID: 31372948 [PubMed – as supplied by publisher]
Aintree – Comment on: The Temporal Relationship between Cancer and Adult Onset Anti-Transcriptional Intermediary Factor 1 Antibody-Positive Dermatomyositis: Reply
Authors: Oldroyd A, Sergeant JC, New RP, McHugh NJ, Betteridge Z, Lamb JA, Ollier WE, Cooper RG, Chinoy H.
Source: Rheumatology (Oxford). 2019 Aug 3. pii: kez329.
doi: 10.1093/rheumatology/kez329. [Epub ahead of print] No abstract available.
PMID: 31377773 [PubMed – as supplied by publisher]
Walton – Supramarginal Resection of Glioblastoma: 5-ALA Fluorescence, Combined Intraoperative Strategies and Correlation with Survival.
Authors: Certo F, Stummer W, Farah JO, Freyschlag C, Visocchi M, Morrone A, Altieri R, Toccaceli G, Peschillo S, Thomè C, Jenkinson M, Barbagallo G.
Source: J Neurosurg Sci. 2019 Jul 29.
doi: 10.23736/S0390-5616.19.04787-8. [Epub ahead of print]
PMID: 31355623 [PubMed – as supplied by publisher]
Walton – Correction to: Incidental Intracranial Meningiomas: A Systematic Review and Meta-Analysis of Prognostic Factors and Outcomes
Authors: Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD.
Source: J Neurooncol. 2019 Jul 31.
doi: 10.1007/s11060-019-03237-5. [Epub ahead of print]
PMID: 31368055 [PubMed – as supplied by publisher]